HC Wainwright Reaffirms “Buy” Rating for 89bio (NASDAQ:ETNB)

HC Wainwright reiterated their buy rating on shares of 89bio (NASDAQ:ETNB – Free Report) in a report issued on Tuesday morning, Benzinga reports. They currently have a $29.00 price target on the stock. HC Wainwright also issued estimates for 89bio’s Q3 2024 earnings at ($0.51) EPS, Q4 2024 earnings at ($0.53) EPS, FY2024 earnings at […]

Leave a Reply

Your email address will not be published.

Previous post Needham & Company LLC Cuts SI-BONE (NASDAQ:SIBN) Price Target to $19.00
Next post Delcath Systems’ (DCTH) “Buy” Rating Reiterated at HC Wainwright